Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Convergent genetic aberrations in murine and human T lineage acute lymphoblastic leukemias.

Huang BJ, Wandler AM, Meyer LK, Dail M, Daemen A, Sampath D, Li Q, Wang X, Wong JC, Nakitandwe J, Downing JR, Zhang J, Taylor BS, Shannon K.

PLoS Genet. 2019 Jun 14;15(6):e1008168. doi: 10.1371/journal.pgen.1008168. eCollection 2019 Jun.

2.

Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models.

Han L, Zhang Q, Dail M, Shi C, Cavazos A, Ruvolo VR, Zhao Y, Kim E, Rahmani M, Mak DH, Jin SS, Chen J, Phillips DC, Bottecelli Koller P, Jacamo R, Burks JK, DiNardo C, Daver N, Jabbour E, Wang J, Kantarjian HM, Andreeff M, Grant S, Leverson JD, Sampath D, Konopleva M.

Haematologica. 2019 May 23. pii: haematol.2018.205534. doi: 10.3324/haematol.2018.205534. [Epub ahead of print]

3.

Novel Brain-Penetrating Oxime Acetylcholinesterase Reactivators Attenuate Organophosphate-Induced Neuropathology in the Rat Hippocampus.

Dail MB, Leach CA, Meek EC, Olivier AK, Pringle RB, Green CE, Chambers JE.

Toxicol Sci. 2019 Jun 1;169(2):465-474. doi: 10.1093/toxsci/kfz060.

PMID:
30835286
4.

In vitro P-glycoprotein activity does not completely explain in vivo efficacy of novel centrally effective oxime acetylcholinesterase reactivators.

Dail MB, Meek EC, Chambers HW, Chambers JE.

Drug Chem Toxicol. 2019 Jul;42(4):403-408. doi: 10.1080/01480545.2018.1461902. Epub 2018 May 3.

PMID:
29722548
5.
6.

Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras.

Akutagawa J, Huang TQ, Epstein I, Chang T, Quirindongo-Crespo M, Cottonham CL, Dail M, Slusher BS, Friedman LS, Sampath D, Braun BS.

Leukemia. 2016 Jun;30(6):1335-43. doi: 10.1038/leu.2016.14. Epub 2016 Feb 12.

7.

Reducing health disparities in underserved communities via interprofessional collaboration across health care professions.

Vanderbilt AA, Dail MD, Jaberi P.

J Multidiscip Healthc. 2015 Apr 21;8:205-8. doi: 10.2147/JMDH.S74129. eCollection 2015.

8.

Species differences in paraoxonase mediated hydrolysis of several organophosphorus insecticide metabolites.

Carr RL, Dail MB, Chambers HW, Chambers JE.

J Toxicol. 2015;2015:470189. doi: 10.1155/2015/470189. Epub 2015 Feb 15.

9.

Beyond mitophagy: cytosolic PINK1 as a messenger of mitochondrial health.

Steer EK, Dail MK, Chu CT.

Antioxid Redox Signal. 2015 Apr 20;22(12):1047-59. doi: 10.1089/ars.2014.6206. Epub 2015 Feb 18. Review.

10.

Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotype.

Coombes RH, Meek EC, Dail MB, Chambers HW, Chambers JE.

Toxicol Lett. 2014 Oct 1;230(1):57-61. doi: 10.1016/j.toxlet.2014.07.029. Epub 2014 Aug 2.

11.

Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia.

Dail M, Wong J, Lawrence J, O'Connor D, Nakitandwe J, Chen SC, Xu J, Lee LB, Akagi K, Li Q, Aster JC, Pear WS, Downing JR, Sampath D, Shannon K.

Nature. 2014 Sep 25;513(7519):512-6. doi: 10.1038/nature13495. Epub 2014 Jul 20.

12.

Paraoxonase 1 polymorphisms within a Mississippi USA population as possible biomarkers of enzyme activities associated with disease susceptibility.

McDaniel CY, Dail MB, Wills RW, Chambers HW, Chambers JE.

Biochem Genet. 2014 Dec;52(11-12):509-23. doi: 10.1007/s10528-014-9663-8. Epub 2014 Jul 16.

PMID:
25027835
13.

The effect of in vitro dieldrin exposure on the rat paraoxonase 1 (pon1) promoter.

Dail MB, Pickin R, Crow JA, Chambers JE.

J Biochem Mol Toxicol. 2014 May;28(5):224-31. doi: 10.1002/jbt.21557. Epub 2014 Mar 10.

PMID:
24615737
14.

The effects of oil exposure on peripheral blood leukocytes and splenic melano-macrophage centers of Gulf of Mexico fishes.

Ali AO, Hohn C, Allen PJ, Ford L, Dail MB, Pruett S, Petrie-Hanson L.

Mar Pollut Bull. 2014 Feb 15;79(1-2):87-93. doi: 10.1016/j.marpolbul.2013.12.036. Epub 2014 Jan 6.

15.

Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1.

Cologna SM, Cluzeau CV, Yanjanin NM, Blank PS, Dail MK, Siebel S, Toth CL, Wassif CA, Lieberman AP, Porter FD.

J Inherit Metab Dis. 2014 Jan;37(1):83-92. doi: 10.1007/s10545-013-9610-6. Epub 2013 May 8.

16.

Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis.

Hartzell C, Ksionda O, Lemmens E, Coakley K, Yang M, Dail M, Harvey RC, Govern C, Bakker J, Lenstra TL, Ammon K, Boeter A, Winter SS, Loh M, Shannon K, Chakraborty AK, Wabl M, Roose JP.

Sci Signal. 2013 Mar 26;6(268):ra21. doi: 10.1126/scisignal.2003848.

17.

Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment.

Cannon JR, Geghman KD, Tapias V, Sew T, Dail MK, Li C, Greenamyre JT.

Exp Neurol. 2013 Feb;240:44-56. doi: 10.1016/j.expneurol.2012.11.007. Epub 2012 Nov 12.

18.

Quantitative proteomic analysis of Niemann-Pick disease, type C1 cerebellum identifies protein biomarkers and provides pathological insight.

Cologna SM, Jiang XS, Backlund PS, Cluzeau CV, Dail MK, Yanjanin NM, Siebel S, Toth CL, Jun HS, Wassif CA, Yergey AL, Porter FD.

PLoS One. 2012;7(10):e47845. doi: 10.1371/journal.pone.0047845. Epub 2012 Oct 29.

19.

Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1.

Cluzeau CV, Watkins-Chow DE, Fu R, Borate B, Yanjanin N, Dail MK, Davidson CD, Walkley SU, Ory DS, Wassif CA, Pavan WJ, Porter FD.

Hum Mol Genet. 2012 Aug 15;21(16):3632-46. doi: 10.1093/hmg/dds193. Epub 2012 May 22.

20.

Relationship of human paraoxonase-1 serum activity and genotype with atherosclerosis in individuals from the Deep South.

Coombes RH, Crow JA, Dail M, Chambers HW, Wills RW; Barry D. Bertolet for CARe, Chambers JE.

Pharmacogenet Genomics. 2011 Dec;21(12):867-875. doi: 10.1097/FPC.0b013e32834cebc6.

21.

Hydroxyl-radical-induced degradative oxidation of beta-lactam antibiotics in water: absolute rate constant measurements.

Dail MK, Mezyk SP.

J Phys Chem A. 2010 Aug 19;114(32):8391-5. doi: 10.1021/jp104509t.

PMID:
20701347
22.

Absolute kinetics and reaction efficiencies of hydroxyl-radical-induced degradation of methyl isothiocyanate (MITC) in different quality waters.

Swancutt KL, Dail MK, Mezyk SP, Ishida KP.

Chemosphere. 2010 Sep;81(3):339-44. doi: 10.1016/j.chemosphere.2010.07.027. Epub 2010 Aug 8.

PMID:
20696459
23.

Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents.

Dail M, Li Q, McDaniel A, Wong J, Akagi K, Huang B, Kang HC, Kogan SC, Shokat K, Wolff L, Braun BS, Shannon K.

Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5106-11. doi: 10.1073/pnas.1001064107. Epub 2010 Mar 1.

24.

Oncogenic Kras initiates leukemia in hematopoietic stem cells.

Sabnis AJ, Cheung LS, Dail M, Kang HC, Santaguida M, Hermiston ML, Passegué E, Shannon K, Braun BS.

PLoS Biol. 2009 Mar 17;7(3):e59. doi: 10.1371/journal.pbio.1000059.

25.

Global liver proteomics of rats exposed for 5 days to phenobarbital identifies changes associated with cancer and with CYP metabolism.

Dail MB, Shack LA, Chambers JE, Burgess SC.

Toxicol Sci. 2008 Dec;106(2):556-69. doi: 10.1093/toxsci/kfn198. Epub 2008 Sep 16.

26.

Spatial distribution of CYP2B1/2 messenger RNA within the rat liver acinus following exposure to the inducers phenobarbital and dieldrin.

Dail MB, Burgess SC, Meek EC, Wagner J, Baravik J, Chambers JE.

Toxicol Sci. 2007 Sep;99(1):35-42. Epub 2007 May 21.

PMID:
17517822
27.

Eph receptors inactivate R-Ras through different mechanisms to achieve cell repulsion.

Dail M, Richter M, Godement P, Pasquale EB.

J Cell Sci. 2006 Apr 1;119(Pt 7):1244-54. Epub 2006 Mar 7.

28.

EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.

Koolpe M, Burgess R, Dail M, Pasquale EB.

J Biol Chem. 2005 Apr 29;280(17):17301-11. Epub 2005 Feb 18.

29.

SHEP1 function in cell migration is impaired by a single amino acid mutation that disrupts association with the scaffolding protein cas but not with Ras GTPases.

Dail M, Kalo MS, Seddon JA, Côté JF, Vuori K, Pasquale EB.

J Biol Chem. 2004 Oct 1;279(40):41892-902. Epub 2004 Jul 22.

30.

An ephrin mimetic peptide that selectively targets the EphA2 receptor.

Koolpe M, Dail M, Pasquale EB.

J Biol Chem. 2002 Dec 6;277(49):46974-9. Epub 2002 Sep 25.

31.

The nucleotide sequence of the Pseudomonas aeruginosa pyrE-crc-rph region and the purification of the crc gene product.

MacGregor CH, Arora SK, Hager PW, Dail MB, Phibbs PV Jr.

J Bacteriol. 1996 Oct;178(19):5627-35.

32.

Growth characteristics, virulence, and cytochemical properties of tubercle bacilli recovered from patients treated with isoniazid.

PATNODE RA, DAIL MC, HUDGINS PC.

Am J Public Health Nations Health. 1955 Apr;45(4):451-6. No abstract available.

33.

Study of the virulence of isoniazid-resistant tubercle bacilli in guinea pigs and mice; a preliminary report.

MORSE WC, WEISER OL, KUHNS DM, FUSILLO M, DAIL MC, EVANS JR.

Am Rev Tuberc. 1954 Mar;69(3):464-8. No abstract available.

PMID:
13138879
34.

A study of the neutral red reaction for determining the virulence of Mycobacteria.

MORSE WC, DAIL MC, OLITZKY I.

Am J Public Health Nations Health. 1953 Jan;43(1):36-9. No abstract available.

Supplemental Content

Support Center